Company intelligence / Profile preview
MedGenesis Therapeutix Inc.
- Ownership
- Private
- Development stage
- Phase 2
Overview
MedGenesis Therapeutix was a Canadian biopharmaceutical company focused on developing and commercializing innovative therapeutics for serious neurological diseases. Its lead program involved delivering recombinant human GDNF directly into the brain using proprietary convection-enhanced delivery technology. The most advanced clinical results were from a Phase II trial in Parkinson's disease supported by grants from organizations such as The Michael J. Fox Foundation and Parkinson's UK. No recent clinical updates or ongoing programs are reported since at least late 2022.
- Therapeutic areas
- Neurology
- Modalities
- Recombinant proteinsDrug-device combination therapies
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on MedGenesis Therapeutix Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MedGenesis Therapeutix Inc..